Bloomage
Bloomage
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.
- All
- News
- Analysis
- Research
In depth
Briefing Dec 09, 2021 10:39 AM
Baijiu plate strength, mouth cellar line exceeds 10%
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
In depth
In depth
Healthcare
Dada group's revenue rose nearly 30% in the third quarter, and JD's "hour purchase" cont
Looking forward to the fourth quarter of 2021, dada Group expects its total revenue to be between 2 billion yuan and 2.1 billion yuan. On the premise that the last kilometer of dada express delivery service is consistent with the comparable basis, the total revenue in the fourth quarter of 2021 will achieve a year-on-year increase of 88% to 97%.
Nov 24, 2021 11:42 AM
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
See more
Related Companies
EqualOcean Analysis
- Wuxi Apptec Embraces a More Health-Conscious China
- Four Growing Stocks to Watch in the Dynamic Chinese Market
- Genetron Health's Self-Developed Mutation Capsule Differentiates It from Others
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.